You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mild hypertension,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Zhengzhou (Antihypertensive drugs, remote ischemic preconditioning(RIPC), lifestyle intervention)

Recruiting
  • Hypertension
  • Antihypertensive drugs
  • +2 more
  • Zhengzhou, Henan, China
    Fuwai central China Cardiovascular hospital
Aug 3, 2022

Hypertension Trial in Beijing (Clonidine controlled-release patch, Amlodipine)

Not yet recruiting
  • Hypertension
  • Beijing, China
    Peking University People's Hospital
Jun 11, 2022

Hypertension Trial in London (Limitless)

Recruiting
  • Hypertension
  • Limitless
  • London, Ontario, Canada
    KGK Science Inc.
Mar 17, 2022

Hypertension Trial in Hangzhou (SHR0532, SHR , Hydrochlorothiazide 25 mg)

Completed
  • Hypertension
  • Hangzhou, Hangzhou, China
    The second Affiliated Hospital Zhejiang University School of Med
Oct 8, 2021

Hypertension Trial in Lahore (mild aerobic exercise, moderate aerobic exercise)

Completed
  • Hypertension
  • mild aerobic exercise
  • moderate aerobic exercise
  • Lahore, Punjab, Pakistan
    Riphah Rehabilitation Center
Dec 7, 2022

Mild Cognitive Impairment, Hypertension Trial in New York

Recruiting
  • Mild Cognitive Impairment
  • Hypertension
    • New York, New York
      Weill Cornell Medicine
    Mar 14, 2023

    Mild Cognitive Impairment, Hypertension Trial in Beijing, Shanghai (Multi-domain adaptive cognitive training, Basic cognitive

    Not yet recruiting
    • Mild Cognitive Impairment
    • Hypertension
    • Multi-domain adaptive cognitive training
    • Basic cognitive training with no difficulty change
    • Beijing, China
    • +1 more
    Jan 20, 2023

    Chronic Thromboembolic Disease Trial in Amsterdam (Balloon Pulmonary Angioplasty (BPA))

    Recruiting
    • Chronic Thromboembolic Disease
    • Balloon Pulmonary Angioplasty (BPA)
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam UMC
    Oct 18, 2023

    Hypertension Trial in Victor Harbor, Geelong (VB0004, Matching Placebo for VB0004)

    Recruiting
    • Hypertension
    • VB0004
    • Matching Placebo for VB0004
    • Victor Harbor, Melbourne, Australia
    • +1 more
    May 2, 2022

    Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks)

    Completed
    • Hypertension
    • MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks
    • (no location specified)
    Feb 7, 2022

    Hypertension Trial (Losartan 50 mg / HCTZ 12.5 mg)

    Completed
    Has Results
    • Hypertension
    • Losartan 50 mg / HCTZ 12.5 mg
    • (no location specified)
    Feb 7, 2022

    Essential Hypertension Trial in China (SPH3127 tablet, Valsartan)

    Recruiting
    • Essential Hypertension
    • Beijing, Beijing, China
    • +13 more
    May 4, 2022

    Erectile Dysfunction, Pulmonary Arterial Hypertension Trial in Changchun (TPN171H)

    Completed
    • Erectile Dysfunction
    • Pulmonary Arterial Hypertension
    • Changchun, China
      The First Affiliated Hospital of Jilin University
    Mar 22, 2022

    Primary Mild and Moderate Hypertension Trial in Suzhou (SPH3127)

    Completed
    • Primary Mild and Moderate Hypertension
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 6, 2022

    Chronic Kidney Disease, Hypertension Trial in Multiple Locations (BAY3283142, Placebo to BAY3283142)

    Not yet recruiting
    • Chronic Kidney Disease
    • Hypertension
    • Multiple Locations, Bulgaria
    • +1 more
    Aug 5, 2022

    Essential Hypertension Trial in Shenzhen (Sacubatril Allisartan medoxomil, Olmesartan Medoxomil)

    Recruiting
    • Essential Hypertension
    • Sacubatril Allisartan medoxomil
    • Olmesartan Medoxomil
    • Shenzhen, Guangdong, China
      Shenzhen People' S Hospital
    Aug 30, 2021

    Essential Hypertension Trial (AZM X mg + AML Y mg, AZM X mg + AML Y' mg, AZM X' mg + AML Y mg)

    Not yet recruiting
    • Essential Hypertension
    • AZM X mg + AML Y mg
    • +7 more
    • (no location specified)
    May 25, 2022

    Hypertension,Essential Trial in China (SPH3127 tablet Dose 1, SPH3127 tablet Dose 2, SPH3127 tablet Dose 3)

    Completed
    • Hypertension,Essential
    • SPH3127 tablet Dose 1
    • +3 more
    • Beijing, China
    • +9 more
    Nov 11, 2021

    Mild to Severe Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks,

    Completed
    • Mild to Severe Hypertension
    • MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks
    • losartan / Duration of Treatment: 6 weeks
    • (no location specified)
    Feb 7, 2022

    Hypertension, Dyslipidemia Trial in Seoul (Duowell®, Telmisartan)

    Completed
    • Hypertension
    • Dyslipidemia
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 4, 2021

    Hypertension, Pregnancy-Induced, Pre-Eclampsia Trial in Maastricht (Labetalol, Nifedipine, Methyldopa)

    Recruiting
    • Hypertension, Pregnancy-Induced
    • Pre-Eclampsia
    • Maastricht, Netherlands
      Maastricht UMC
    Mar 23, 2021

    Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Miami, Orlando (Ampreloxetine)

    Completed
    • Symptomatic Neurogenic Orthostatic Hypertension
    • nOH
    • Miami, Florida
    • +1 more
    Sep 7, 2021

    Hypertension Trial in Tokyo (SPP100 (aliskiren))

    Completed
    • Hypertension
    • SPP100 (aliskiren)
    • Tokyo, Japan
      Novartis Investigative Site
    Dec 17, 2020

    Hypertension Trial in India (Aliskiren)

    Completed
    • Hypertension
    • Coimbatore, India
    • +4 more
    Dec 17, 2020

    Comorbidities and Coexisting Conditions, Alzheimer, Dementia Trial in Albacete (Intervention tested (CAREPATH))

    Not yet recruiting
    • Comorbidities and Coexisting Conditions
    • +14 more
    • Intervention tested (CAREPATH)
    • Albacete, Spain
      Complejo Hospitalario Universitario de Albacete
    Nov 2, 2021